Balyasny Asset Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Balyasny Asset Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,622	Closed	-$145K	–	3202
2023 Q1	$145K	Buy	14,622 +1,916	+15%	+$19K	﹤0.01%	2274
2022 Q4	$127K	Buy	+12,706	New	+$94.7K	﹤0.01%	2214
2022 Q3	–	Sell	-12,056	Closed	-$44K	–	3402
2022 Q2	$44K	Buy	+12,056	New	+$57K	﹤0.01%	2384
2022 Q1	–	Sell	-20,139	Closed	-$170K	–	3009
2021 Q4	$170K	Buy	+20,139	New	+$176K	﹤0.01%	1885

Balyasny Asset Management's APEN Position: Q2 2023 in Review

Balyasny Asset Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 14,622 shares — an estimated $145K sold.

Balyasny Asset Management first reported a position in APEN in Q4 2021 and held it in 4 quarters. The position peaked at $170K in Q4 2021. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Balyasny Asset Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Balyasny Asset Management sold 14,622 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $145K.
Balyasny Asset Management first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 4 quarters.
Balyasny Asset Management's Apollo Endosurgery, Inc. position peaked at $170K in Q4 2021.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.